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Aims: We present a new method to detect mutations in the CFTR gene based in 
heteroduplex analysis by capillary aTray electrophoresis (HA CAE). The purpose is 
to optimize the t ime for analysis ample and the accuracy of mutation detection. 
CFTR neonatal screening has demostr ated to be very important in order to improve 
the quality of l ife of the CF patients. A wide range of techniques can be used to 
identify mutations mad polymorphisms in the CFTR gene. These methods can be 
divided into two groups: mutation specific methods and generic methods, and some 
of them are t ime consuming (sequencing ...) or expensives (OLA, ....). The HA 
CAE method have demonstrated to be faster and more effective than other classical 
methods and with a low cost. 
The method was developed in a 3100 Abi  Prism automatic sequencer with primers 
labeled with FAM in the 5"position. We analyse exon 10 (containing F508del 
mutation: 61%of CFTR mutations in our population) mad usind the multiplex PCR 
method we amplify exons 11, 14b and 17b (14%) and 12 and 7 (7.35%). With these 
tbree PCR reactions we can analyse the 82.35% of our CFTR mutations, 
overcoming the 80% mutation detection rate reccomended by the European 
Concerted Action of CF. 
Conclusion: this is a suitable method for CF neonatal screening in our population. 
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OJ s~ic fibrosis (CF; #2197120) is a disorder caused by mutations in the CF IR  gene, 
characterized by a wide variability of cl inical expressions modulated by "modifier 
genes". Recently, biochemical and functional analysis of CFTR, revealed that this 
protein interacts with protein containing multiple FDZ domain (Cftr Associated 
Protein 70 kDa, N/H Exchanger Regulatory Factor). We studied a human homolog 
of the mouse FDZK1, CAP70, as a candidate CF modifier gene. CAP70 maps on 
lq21 mad is organized in 8 exons which encode a mRNA of 2.2Kb. The gene 
presents three actively transcribed copies, but one of these is translated in a 
functional protein product. We genotyped CAP70 in a court of CF patients with 
pancreatic insuff iciency (PI 36) mad hepatic involvement and pancreatic 
insufficiency (EI 31). Results were compared with a matched age normal controls 
(C 35). Genotypes at SNP IVS4 92 A/G (rs9726178) upstream of the exon 5 were 
examined by Pyrosequencing technology to determine the al lele copies in a 
triplicate gene assay. This method is able to reveal seven different al lele 
combinations (6AOG; 5AIG;  4A2G; 3A3G; 2A4G; 1A5G; 0A6G ). The allelic 
distribution was different within CF phenotypic lasses compared (Chi square test: 
p~).012), ha particular, 3A3G were underrepresented within the PI CF patients 
(p~).008), whi le  5A1G, 6AOG, 0A6G, 1A5G were ovetrepresented in this group of 
patients (.3 0.1207). 
These data strongly suggest a role for CAP70 gene as modifier of the CF phenotype. 
